Roche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study
The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic ...
ophthalmologytimes16d
Paper: Rising diabetic retinopathy rates in youth signal potential public health crisis
A recent paper reveals increasing rates of diabetic retinopathy in young patients with diabetes, sparking concerns over ...
Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024
About the Phase 3 DIAMOND Program of OCS-01 in Diabetic Macular Edema ...
Fighting ophthalmic disease that causes blindness
New AI-driven test identifies diabetic retinopathy risk, promising better care for patients in Israel and beyond.
Analytics Insight5d
Google's Vision for AI in India: Major Focus
While India is climbing the ladder of economic growth, Google ensured that India's AI vision is both bold and transformative, ...
emjreviews.com3d
AI and Diabetes Technology in Diabetic Complications
IN AN INSIGHTFUL session presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024, the ...
Khaleej Times on MSN9d
UAE doctors warn eye infections may lead to permanent vision loss
A 54-year old UAE resident nearly went blind recently following a severe corneal infection that worsened post-eye surgery.
manilatimes7d
Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees
Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum ...